Australia, Dec. 2 -- ImmunityBio Inc., owns the trademark (2587850) for 'ANKTIGEN' till Aug. 18, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections; pharmaceutical preparations for use in stimulating lymphocyte production; pharmaceutical preparations for maintenance of lymphocyte counts.]
Type of Mark: Word
Date of Acceptance: Sept. 23
Registration Advertised: Dec. 1
For further details contact Alicia M. Passerin Leech Tishman Fuscaldo & Lampl.
The original document can be viewed at: https://search.ipaus...